Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|ALXN||Alexion Pharmaceuticals, Inc.||0.00%||182.50||2.0%||$1481.47m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-4.84%||10.61||0.7%||$741.68m|
|NTLA||Intellia Therapeutics, Inc.||-6.88%||137.71||2.3%||$600.33m|
|VRTX||Vertex Pharmaceuticals, Inc.||2.29%||200.50||1.9%||$451.71m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.09%||586.35||2.7%||$444.01m|
|GILD||Gilead Sciences, Inc.||0.54%||69.02||1.0%||$387.27m|
|CRSP||CRISPR Therapeutics AG||-2.00%||122.27||0.6%||$200.86m|
|EXAS||EXACT Sciences Corp.||-0.07%||117.95||18.1%||$129.94m|
Alexion Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.